Mode
Text Size
Log in / Sign up
N/A N=6 Randomized Single-blind Supportive Care

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

Dementia · Mild Cognitive Impairment · Alzheimer Disease

Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: 3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D) — 32.33 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
In-Home Technology System (Device); Limited In-Home Technology (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, Berkeley
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)
32.33
PRIMARY
6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)
29.5
PRIMARY
3 Months Assessment for Zarit Burden Interview-Short Form
25.67
PRIMARY
6 Months Assessment for Zarit Burden Interview-Short Form
26.5
PRIMARY
3 Months Assessment for Beck Anxiety Inventory (BAI)
13.67
PRIMARY
6 Months Assessment for Beck Anxiety Inventory (BAI)
14
PRIMARY
3 Months Assessment for Satisfaction With Life Scale
14.33
PRIMARY
6 Months Assessment for Satisfaction With Life Scale
14.5

Summary

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.

Eligibility Criteria

Inclusion Criteria

  • Caregivers speak Spanish in their homes
  • Caregivers currently reside in the United States with spouse/family member who has received a medical diagnosis of Alzheimer's disease, other dementia, or mild cognitive impairment
  • Caregivers primarily use a smartphone (e.g., iPhone, Android)
  • Caregivers have internet and WiFi service

Exclusion Criteria

  • Caregivers providing care for individuals with known non-neurodegenerative conditions affecting behavior and cognition
  • Caregivers providing care for individuals with longstanding Axis I psychiatric disorder
  • Caregivers providing care for individuals with metabolic disorder or major organ dysfunction
  • Caregivers providing care for individuals with alcohol abuse or dependence (within 5 years of dementia onset)
  • Caregivers providing care for individuals with head trauma with loss of consciousness greater than 30 minutes
  • Caregivers providing care for individuals with contraindications to MRI imaging
  • Caregivers providing care for individuals with large confluent white matter lesions
  • Caregivers providing care for individuals with significant systemic medical illness
  • Caregivers providing care for individuals who use a medication likely to affect central nervous system functions adversely
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05159596). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search